Article
Inhibition of human immunodeficiency virus by a new class of pyridine oxide derivatives.
Antimicrobial agents and chemotherapy - 1 Sept 2003
Stevens Miguel, Pannecouque Christophe, De Clercq Erik, Balzarini Jan
Abstract excerpt
A new class of pyridine oxide derivatives as inhibitors of human immunodeficiency virus type 1 (HIV-1) and/or HIV-2 replication in cell culture has been identified. The compounds, which specifically inhibit HIV-1, behave as typical nonnucleoside reverse transcriptase inhibitors (NNRTIs). The most active congener of this group, JPL-133 (UC-B3096), has a 50% effective concentration of 0.05 microg/ml for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
